Remetinostat Uses, Dosage, Side Effects and more
Remetinostat is under investigation in clinical trial NCT02213861 (Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma).
| Attribute | Details |
|---|---|
| Trade Name | Remetinostat |
| Generic | Remetinostat |
| Remetinostat Other Names | Remetinostat |
| Type | |
| Formula | C16H21NO6 |
| Weight | Average: 323.345 Monoisotopic: 323.1368874 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
